Replies to Post #37 onCoLucid Pharmaceuticals (CLCD)

Replies to post #37 on CoLucid Pharmaceuticals (CLCD)

Replies to #37 on CoLucid Pharmaceuticals (CLCD)

09/19/16 8:06 AM

#38 RE: DewDiligence #37

CLCD Ladenburg Thalmann making positive comments, PT $57, ph 3 data detail bolsters Lasmiditan. Firm believes M&A is a possibility

09/19/16 11:12 AM

#40 RE: DewDiligence #37

CLCD reports update from GLADIATOR safety study: #msg-125245097.

10/05/16 12:05 PM

#44 RE: DewDiligence #37

CLCD reports additional data from SAMURAI study:

http://finance.yahoo.com/news/colucid-pharmaceuticals-announces-additional-analyses-145443436.html